Skip to main content
. 2020 Jul 27;9(8):451. doi: 10.3390/antibiotics9080451

Figure 2.

Figure 2

Estimated creatinine clearance values for patients with and without AKI during the start of high-dose polymyxin B therapy (baseline), lowest value during high-dose polymyxin B therapy (worst), end of high-dose polymyxin B therapy (end of therapy) and at discharge or death (final). * p < 0.05 compared to baseline creatinine clearance values.